Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A
Adv Ther. 2024 Apr 15. doi: 10.1007/s12325-024-02834-9. Online ahead of print. ABSTRACT INTRODUCTION: A prospective, non-interventional study (270-902) followed 294 adults with severe hemophilia A …